Chemleader Biomedical-Small Molecules 丨Intermediates 丨Drug Impurities

(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺

Navitoclax (Synonyms: ABT-263; A-855071)

ChemLeader 98+%

产品编号：CL2346

CAS No.：923564-51-6

MDLNo：

分子式：C47H55ClF3N5O6S3

分子量：974.61

下载MSDS 下载COA

选择规格

5 mg 10 mg

产品库存

In-stock

目录价格

￥480.00

会员价格

登录后可见

产品库存

In-stock

目录价格

￥760.00

会员价格

登录后可见

选择数量

- +

发送询价加入购物车

基本信息

中文名称	(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺
英文名称	Navitoclax (Synonyms: ABT-263; A-855071)
CAS号	923564-51-6
分子式	C47H55ClF3N5O6S3
分子量	974.61
外观	White to light yellow powder
储存条件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

安全信息

产品详情

Navitoclax, also known as ABT-263, is an orally bioavailable, synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w and prevents their binding to the apoptotic effectors Bax and Bak proteins, which may trigger apoptosis in tumor cells overexpressing Bcl-2, Bcl-XL, and Bcl-w.
Tags: buy Navitoclax (ABT-263) | purchase Navitoclax (ABT-263) | Navitoclax (ABT-263) cost | order Navitoclax (ABT-263) | Navitoclax (ABT-263) chemical structure | Navitoclax (ABT-263) in vivo | Navitoclax (ABT-263) in vitro | Navitoclax (ABT-263) formula | Navitoclax (ABT-263) molecular weight

相关产品

抱歉，暂时没有相关产品

浏览记录

(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺

￥480.00